These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34322485)

  • 1. Predicting Panel of Metabolism and Immune-Related Genes for the Prognosis of Human Ovarian Cancer.
    Zhang L; Sun W; Ren W; Zhang J; Xu G
    Front Cell Dev Biol; 2021; 9():690542. PubMed ID: 34322485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer.
    Zhang J; Wang L; Xu X; Li X; Guan W; Meng T; Xu G
    Front Oncol; 2020; 10():1787. PubMed ID: 33042828
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
    Chen B; Gao C; Wang H; Sun J; Han Z
    Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
    Diao B; Yang P
    Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer.
    Yang J; Hong S; Zhang X; Liu J; Wang Y; Wang Z; Gao L; Hong L
    Front Oncol; 2021; 11():807410. PubMed ID: 34966691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three Genes Predict Prognosis in Microenvironment of Ovarian Cancer.
    Guo Y; Wang YL; Su WH; Yang PT; Chen J; Luo H
    Front Genet; 2020; 11():990. PubMed ID: 32983229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
    Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY
    Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer.
    Lu W; Xie B; Tan G; Dai W; Ren J; Pervaz S; Li K; Li F; Wang Y; Wang M
    Front Endocrinol (Lausanne); 2023; 14():1088944. PubMed ID: 36742380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the biological functions and chemo-therapeutic responses of ITGB superfamily in ovarian cancer.
    Han J; Lyu L
    Discov Oncol; 2024 May; 15(1):198. PubMed ID: 38814534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer.
    Xie B; Tan G; Ren J; Lu W; Pervaz S; Ren X; Otoo AA; Tang J; Li F; Wang Y; Wang M
    Front Oncol; 2022; 12():830908. PubMed ID: 35299734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
    Jiao J; Jiang L; Luo Y
    Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
    He T; Huang L; Li J; Wang P; Zhang Z
    Front Med (Lausanne); 2021; 8():587496. PubMed ID: 34109184
    [No Abstract]   [Full Text] [Related]  

  • 17. Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response.
    Zhang H; Wu Y; Li H; Sun L; Meng X
    Cancer Cell Int; 2021 Nov; 21(1):593. PubMed ID: 34736480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prognostic Model Based on Metabolism-Related Genes for Patients with Ovarian Cancer.
    Jian D; Lianghao Z; Yunge G; Ligang C; Biliang C; Xiaohui L
    Dokl Biochem Biophys; 2023 Jun; 510(1):110-122. PubMed ID: 37582873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer.
    Zhu X; You S; Du X; Song K; Lv T; Zhao H; Yao Q
    BMC Med Genomics; 2023 Jan; 16(1):10. PubMed ID: 36653841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
    Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
    J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.